JY
KYMR icon

Jeff Yass’s Kymera Therapeutics KYMR Stock Holding History

Jeff Yass’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
120,300
+55,800
+87% +$4.79M ﹤0.01% 2909
2026
Q1 		$5.37M Buy
64,500
+17,800
+38% +$1.41M ﹤0.01% 4104
2025
Q4 		$3.63M Sell
46,700
-43,900
-48% -$2.96M ﹤0.01% 4552
2025
Q3 		$5.13M Buy
90,600
+35,400
+64% +$1.6M ﹤0.01% 4053
2025
Q2 		$2.41M Buy
55,200
+22,900
+71% +$789K ﹤0.01% 5388
2025
Q1 		$884K Buy
32,300
+17,900
+124% +$653K ﹤0.01% 7556
2024
Q4 		$579K Sell
14,400
-6,100
-30% -$276K ﹤0.01% 8305
2024
Q3 		$970K Buy
+20,500
New +$905K ﹤0.01% 6851
2024
Q2 		– Sell
-6,900
Closed -$277K – 12707
2024
Q1 		$277K Sell
6,900
-12,700
-65% -$454K ﹤0.01% 9876
2023
Q4 		$499K Buy
19,600
+4,400
+29% +$78.7K ﹤0.01% 8671
2023
Q3 		$211K Buy
15,200
+200
+1% +$4.02K ﹤0.01% 10115
2023
Q2 		$345K Sell
15,000
-204,700
-93% -$5.87M ﹤0.01% 9161
2023
Q1 		$6.51M Sell
219,700
-54,800
-20% -$1.77M ﹤0.01% 3059
2022
Q4 		$6.85M Buy
274,500
+264,600
+2,673% +$7.06M ﹤0.01% 2772
2022
Q3 		$216K Buy
+9,900
New +$261K ﹤0.01% 10643
2022
Q2 		– Sell
-8,100
Closed -$343K – 13468
2022
Q1 		$343K Buy
8,100
+3,100
+62% +$131K ﹤0.01% 9936
2021
Q4 		$317K Buy
+5,000
New +$291K ﹤0.01% 10349
2021
Q3 		– Sell
-26,900
Closed -$1.3M – 13186
2021
Q2 		$1.3M Buy
+26,900
New +$1.17M ﹤0.01% 7022

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jeff Yass's KYMR Position: Q2 2026 in Review

Jeff Yass reduced its Kymera Therapeutics (KYMR) stake by 80% in Q2 2026, selling an estimated $1.75M and leaving 5,061 shares worth $580K. The position accounts for ﹤0.01% of the portfolio, ranked #9563.

Jeff Yass first reported a position in KYMR in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.51M in Q2 2025. 274 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Jeff Yass held 5,061 shares of Kymera Therapeutics worth $580K as of Q2 2026.
  • Jeff Yass sold 20,342 Kymera Therapeutics shares in Q2 2026, an estimated $1.75M.
  • Kymera Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9563 holding.
  • Jeff Yass first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Jeff Yass's Kymera Therapeutics position peaked at $2.51M in Q2 2025.
  • 274 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.